A prospective study of palonosetron for prevention of chemotherapy-induced nausea and vomiting in malignant lymphoma patients following highly emetogenic chemotherapy
Crossref DOI link: https://doi.org/10.1007/s10147-017-1173-3
Published Online: 2017-08-19
Published Print: 2018-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Takahashi, Tsutomu
Okada, Takahiro
Ikejiri, Fumiyoshi
Ito, Shunsuke
Okada, Yusuke
Takahashi, Fumimasa
Kumanomido, Satoshi
Jo, Yumi
Adachi, Koji
Onishi, Chie
Kawakami, Koshi
Miyake, Takaaki
Inoue, Masaya
Suzuki, Ritsuro
Suzumiya, Junji
License valid from 2017-08-19